Jane Street
QTTB icon

Jane Street’s Q32 Bio QTTB Stock Holding History

Jane Street’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-639
Closed -$123K – 8226
2020
Q3 		$123K Buy
+639
New +$143K ﹤0.01% 6688

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's QTTB Position: Q1 2026 in Review

Jane Street increased its Q32 Bio (QTTB) stake by 159% in Q1 2026, buying an estimated $191K and bringing the position to 65,599 shares worth $421K. The position accounts for ﹤0.01% of the portfolio, ranked #8448.

Jane Street first reported a position in QTTB in Q3 2020 and has held it in 8 quarters since. The position peaked at $733K in Q3 2024. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Jane Street held 65,599 shares of Q32 Bio worth $421K as of Q1 2026.
  • Jane Street bought 40,225 Q32 Bio shares in Q1 2026, an estimated $191K.
  • Q32 Bio made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8448 holding.
  • Jane Street first reported a position in Q32 Bio in Q3 2020 and has held it in 8 quarters since.
  • Jane Street's Q32 Bio position peaked at $733K in Q3 2024.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.